吕博, 陈赟, 李云海. Outcomes and clinical prognostic factors for elderly patients with esophageal squamous cell carcinoma treated after definitive chemoradiotherapy[J]. China Oncology, 2015, 25(3): 217-221.
Background and purpose: With the increase of aging population
elderly patients (age ≥70 years) with esophageal squamous cell carcinoma occurred more and more. However
few studies have focused on elderly esophageal squamous cell carcinoma patients. This study aimed to assess the outcomes and prognostic factors for elderly patients with esophageal squamous cell carcinoma treated after definitive chemoradiotherapy. Methods: We retrospectively analyzed 53 patients (age ≥70 years) with esophageal squamous cell carcinoma and treated with definitive radiotherapy with or without chemotherapy from Fudan University Shanghai Cancer Center from Mar. 2009 to Dec. 2011. Results: Median age was 74 years. Twenty-nine patients underwent radiotherapy
24 patients underwent radiochemotherapy. 1-
2-
3-
and 5- year survival was 62%
44%
33% and 19% respectively. Grade 2 and above acute radiation-induced esophageal toxicity and radiation pneumonitis occur rate was 6% and 9% respectively. No treatment-related deaths occurred and no patients experienced any grade 4 and above toxicities. Multivariate analysis identified treatment modality
tumor site and smoking history as independent prognostic factors for overall survival. Conclusion: Radiotherapy may be an acceptable treatment option for elderly patients with esophageal squamous cell carcinoma. In appropriately selected patients
concurrent chemotherapy could bring a better overall survival.
Risk of cancer therapy-related cardiotoxicity following the use of PD-1/PD-L1 inhibitors combined with chemoradiotherapy compared with chemoradiotherapy in solid tumors: a systematic review and Meta-analysis
Prognostic values of hematological biomarkers in locoregionally advanced nasopharyngeal carcinoma
Related Author
ZHENG Jinmei
WU Wanghui
ZHENG Jimei
LIU Ji
WU Fei
WANG Mingxuan
SU Qiang
孙健达
Related Institution
Department of Oncology, Beijing Friendship Hospital Capital Medical University
Department of Pathology, School of Basic Medical Sciences of Fujian Medical University
Zhangzhou Changtai District Hospital
Department of Emergency, Beijing Friendship Hospital Capital Medical University